Decisions, Decisions | GenomeWeb

Decisions, Decisions

In a unanimous decision yesterday, the US Supreme Court ruled in the Association for Molecular Pathology et al. v. Myriad Genetics case that human genes are not patent-eligible, though it also said that cDNA is eligible to be patented as it is not naturally occurring. The case centered on the BRCA1 and BRCA2 breast cancer genes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.